article thumbnail

Social Media Advertising for Pharma: Strategies to Boost Engagement & Compliance

Pharma Marketing Network

This article explores effective social media advertising strategies tailored for pharmaceutical marketing executives , helping them navigate compliance and create impactful campaigns. Ensuring Compliance in Pharma Social Media Ads Navigating regulatory compliance in pharma social media advertising is one of the biggest challenges.

article thumbnail

Alyftrek: Vertex Expands Cystic Fibrosis Treatment with Triple-Action Combo

XTalks

The US Food and Drug Administration (FDA) has approved Alyftrek (vanzacaftor/tezacaftor/deutivacaftor), a next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator, to treat cystic fibrosis (CF) in patients aged six years and older with at least one F508del mutation or another responsive CFTR mutation.

Protein 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transforming drug development with AI

pharmaphorum

Discover how artificial intelligence (AI) is revolutionising the drug development process and transforming the way FDA-approved drugs are produced, ensuring compliance and optimising the supply chain. Learn more about the future of AI in pharmaceuticals.

article thumbnail

FDA Refines Accelerated Approval Pathway with New Draft Guidance

XTalks

Notably, the FDA can now mandate that confirmatory trials begin before approval, ensuring proactive validation of clinical benefits. The draft also formalizes withdrawal procedures for non-compliance, including delayed studies or failure to confirm benefits.

article thumbnail

Email Marketing Campaigns for Pharma: Boost Engagement & Compliance

Pharma Marketing Network

This guide explores the best strategies for boosting engagement while ensuring compliance , helping pharma brands connect with their audiences more effectively. Regulatory-Friendly Communication : Unlike social media ads, emails offer controlled messaging that aligns with compliance regulations.

article thumbnail

LumiThera’s Valeda Photobiomodulation System Gets FDA Authorization for Dry AMD

XTalks

Unlike its counterpart, wet AMD, which involves abnormal blood vessel growth, dry AMD lacks effective, FDA-approved treatment options, leaving patients at risk of significant vision loss. AMD is a leading cause of vision loss for people aged 65 and older.

article thumbnail

Tamibarotene Fails in Phase III Trial for a Subset of Higher-Risk MDS

XTalks

In June, Geron’s telomerase inhibitor Rytelo (imetelstat) won FDA approval for patients with low- to intermediate-risk MDS with transfusion-dependent anemia. MDS are a group of blood disorders caused by abnormal development of blood cells in the bone marrow.

Trials 105